Attovia Therapeutics’ Post

View organization page for Attovia Therapeutics, graphic

2,549 followers

We are excited to announce our $105M Series B funding! We're deeply grateful to both our new and existing investors for their commitment to transforming medicine through the ATTOBODY technology. We are also proud of our team at Attovia, whose dedication and innovation were instrumental to reaching this milestone. With this support, we're optimally equipped to advance our programs into the clinic. Learn more here: https://bit.ly/3URSn19 #ATTOBODY #Attovia #Immunology #SeriesB

  • No alternative text description for this image
Agnaldo Shyton

Cap Table Management | Cap Table Audit | 409A Valuations | Carta Partner | Private Equity | Funding

3mo

Attovia Therapeutics, should you need any assistance with adjustments to your Cap Table, please don't hesitate to reach out. We're a trusted partner of Carta, boasting extensive experience managing over 2,000 cap tables. Warm congratulations

Like
Reply
Jesse Ceja

Clinical Solutions | Precision for Medicine

3mo

Congratulations on the growth!

Like
Reply
Keegan Pham

Senior Research Associate @ Attovia Therapeutics | Molecular and Cell Biologist

3mo

Very exciting news!

Like
Reply
Md Abul Fazal

22K+Pharmaceutical Professionals connection Across the World.Pharma finished Products Exporter.Emergency patient support,Oncology, Hematology, Antiviral.

3mo

Impressive growth!

Like
Reply

Congratulations! Very exciting!

Like
Reply
Alex Cocleaza, MS, MBA

Biotech Strategic Operator | Transactions (Buyside & Sellside) | External Financing | Ex-Banking

3mo

Congratulations Zaneta Odrowaz !!

Like
Reply
Christopher Silva

VP, Marketing and Product @ Carterra | Drug Discovery

3mo

Congratulations!

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics